Anifrolumab vs Buprenorphine

## Anifrolumab vs Buprenorphine: Overview

This comparison examines the pharmacological differences between **Anifrolumab** and **Buprenorphine**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

## Pharmacokinetics

**Half-life**: Anifrolumab — N/A; Buprenorphine — 24-42 hours.

## Chemical Properties

**Molecular Formula**: Anifrolumab — N/A; Buprenorphine — C29H41NO4.

**Molecular Weight**: Anifrolumab — N/A; Buprenorphine — 467.6430 g/mol.

**Type**: Anifrolumab — Antibody; Buprenorphine — Small molecule.